These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6373442)

  • 1. A double-blind multicentre study of piretanide and hydrochlorothiazide in patients with essential hypertension.
    Buckert C; Muhlhausler W; Fratzer U; Verho M
    J Int Med Res; 1984; 12(2):81-6. PubMed ID: 6373442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piretanide in the treatment of essential hypertension. A double-blind comparison versus placebo.
    Verho M; Rangoonwala B; Beloso M; Maass L; Bender R; Garduno D
    Drugs Exp Clin Res; 1986; 12(5):385-91. PubMed ID: 3522159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piretanide, a potassium stable diuretic, in the treatment of essential hypertension.
    Verho M; Rangoonwala B; Dols W; Fratzer U; Kaczynski J; Mühlhäusler W
    Eur J Clin Pharmacol; 1984; 27(4):407-14. PubMed ID: 6394349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piretanide, a potassium stable diuretic, in the treatment of essential hypertension: a double-blind comparison of two formulations.
    Dols W; Verho M; Rangoonwala B; Jaeger S
    J Int Med Res; 1985; 13(1):31-9. PubMed ID: 3884409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single and divided daily dose piretanide in the treatment of uncomplicated essential hypertension: a double-blind comparison with a combination of hydrochlorothiazide and amiloride.
    Verho M; Rangoonwala B; Dols W
    Eur J Clin Pharmacol; 1985; 29(3):269-73. PubMed ID: 3908125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of slow-release piretanide and bendroflumethiazide in the treatment of mild to moderate hypertension.
    Hegbrant J; Skogström K; Månsby J
    J Int Med Res; 1989; 17(5):426-34. PubMed ID: 2680677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum trace-element levels in piretanide-treated hypertensives: a double-blind trial against hydrochlorothiazide plus amiloride.
    Verho M; Bossaller W; Heinen B
    Int J Clin Pharmacol Res; 1987; 7(1):5-11. PubMed ID: 3294616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of piretanide capsules on blood pressure during ergometric and isometric work loads in patients with mild to moderate essential hypertension.
    Meywald W; Maass L; Verho M; Rangoonwala B
    Pharmatherapeutica; 1985; 4(6):356-66. PubMed ID: 4080753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of piretanide on catecholamine metabolism, plasma renin activity and serum aldosterone: a double-blind pilot comparison against hydrochlorothiazide in patients with essential hypertension.
    Verho M; Kirsten R; Bückert C
    Pharmatherapeutica; 1984; 3(9):595-606. PubMed ID: 6374680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum selenium levels in diuretic-treated hypertensives: a double-blind trial of piretanide against hydrochlorothiazide plus amiloride.
    Verho M; Bossaller W; Malerczyk V
    Int J Clin Pharmacol Res; 1988; 8(1):5-8. PubMed ID: 3284831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of penbutolol + piretanide combinations in the treatment of arterial hypertension.
    Verho M; Rangoonwala B; Pahnke K; Freude J; Häringer E
    Drugs Exp Clin Res; 1985; 11(10):717-23. PubMed ID: 3915460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized double-blind clinical trial of xipamid and hydrochlorothiazide in essential hypertension.
    Kumar S; Pandhi P; Wahi PL; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):549-51. PubMed ID: 6392119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diuretic monotherapy in heart failure. Comparison of piretanide and hydrochlorothiazide-triamterene].
    Gonska BD; Kreuzer H
    Dtsch Med Wochenschr; 1985 Nov; 110(47):1812-6. PubMed ID: 3905326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two combined diuretics in the treatment of essential hypertension.
    Verhiest W; Baehre M; Volkers P
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):342-5. PubMed ID: 2674028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparison of a novel indanone diuretic (MK-196) with hydrochlorothiazide in the treatment of essential hypertension.
    Wilhelmsson CE; Vedin JA; Moerlin C; Lund-Johansen P; Vorburger C; Enenkel W; Lutterbeck PM; Bolognese J; Cirillo VJ; Tempero KF
    Br J Clin Pharmacol; 1979 Sep; 8(3):261-6. PubMed ID: 387057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Eurevie Study: contrasting effect of piretanide and thiazides in mild to moderate hypertension.
    Charansonney OL; Lièvre M; Laville M; Lion L; Derobert E; Visèle N; Decourt S; de Rusunan MP; Luciani J; Vasmant D; Boissel JP; Grünfeld JP
    Therapie; 1997; 52(3):169-77. PubMed ID: 9366100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of piretanide, a potassium stable diuretic, on serum electrolytes in patients with congestive heart failure.
    Verho M; Bückert C; Freude J; Jaeger S; Pahnke K
    Pharmatherapeutica; 1985; 4(5):288-95. PubMed ID: 3906674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of piretanide plus ramipril for systemic hypertension: a multicenter trial.
    Homuth V; Faulhaber HD; Loose U; Löffler K; Luft FC
    Am J Cardiol; 1993 Sep; 72(9):666-71. PubMed ID: 8249842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Captopril/hydrochlorothiazide combination in elderly patients with mild-moderate hypertension. A double-blind, randomized, placebo-controlled study.
    Creisson C; Baulac L; Lenfant B
    Postgrad Med J; 1986; 62 Suppl 1():139-41. PubMed ID: 3534849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind comparison of antihypertensive treatment with ramipril and piretanide, given alone or in combination.
    Thijs L; Celis H; Kiowski W; Löffler K; Middeke M; Schulz W; Staessen J; Amery A
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):33-8. PubMed ID: 7564362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.